WO2006045054A2 - Dispositif de stimulation du corps neuromusculaire, peripherique et stimulation(s) electrique(s) dans la suberification d'une blessure par recuperation d'energie radioelectrique - Google Patents
Dispositif de stimulation du corps neuromusculaire, peripherique et stimulation(s) electrique(s) dans la suberification d'une blessure par recuperation d'energie radioelectrique Download PDFInfo
- Publication number
- WO2006045054A2 WO2006045054A2 PCT/US2005/037928 US2005037928W WO2006045054A2 WO 2006045054 A2 WO2006045054 A2 WO 2006045054A2 US 2005037928 W US2005037928 W US 2005037928W WO 2006045054 A2 WO2006045054 A2 WO 2006045054A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stimulation
- chip
- implantable
- radio frequency
- circuit
- Prior art date
Links
- 230000000638 stimulation Effects 0.000 title claims abstract description 74
- 238000003306 harvesting Methods 0.000 title claims abstract description 42
- 230000029663 wound healing Effects 0.000 title description 5
- 230000002093 peripheral effect Effects 0.000 title description 3
- 210000001186 vagus nerve Anatomy 0.000 claims description 13
- 230000007383 nerve stimulation Effects 0.000 claims description 8
- 210000003205 muscle Anatomy 0.000 claims description 5
- 208000024827 Alzheimer disease Diseases 0.000 claims description 4
- 208000006373 Bell palsy Diseases 0.000 claims description 4
- 230000002496 gastric effect Effects 0.000 claims description 4
- 208000036826 VIIth nerve paralysis Diseases 0.000 claims description 3
- 238000012377 drug delivery Methods 0.000 claims description 3
- 208000008589 Obesity Diseases 0.000 claims description 2
- 206010033799 Paralysis Diseases 0.000 claims description 2
- 235000020824 obesity Nutrition 0.000 claims description 2
- 208000021401 Facial Nerve injury Diseases 0.000 claims 1
- 238000004146 energy storage Methods 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 238000002513 implantation Methods 0.000 description 6
- 230000006872 improvement Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 239000003990 capacitor Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 230000002232 neuromuscular Effects 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 208000001654 Drug Resistant Epilepsy Diseases 0.000 description 1
- 206010015995 Eyelid ptosis Diseases 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- 208000009668 Neurobehavioral Manifestations Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000028552 Treatment-Resistant Depressive disease Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000001288 gastroparesis Diseases 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001769 paralizing effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
- A61N1/3787—Electrical supply from an external energy source
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36053—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for vagal stimulation
Definitions
- the present invention relates generally to systems and apparatus for providing electrical stimulation and more particularly to a device or a chain of devices for harvesting radio frequency (RF) energy that can be implanted in the human body to produce electrical stimulation in different regions of the body.
- RF radio frequency
- the device of the invention could be a chip or a nano or molecular system.
- Synchronized neuromuscular stimulation encompasses conditions in which unilateral paralysis can be restored by using a RF signal to coordinate the contraction between a functional and paralytic muscle.
- One application is facial nerve paralysis, often due to Bell's palsy. About 80,000 Americans a year are diagnosed with Bell's palsy and of those, 1O% to 15% are left with permanent visible defects such as ptosis of one side of the face.
- RF harvesting has been published in the following article ("Communication between Functional and Denervated Muscles using Radio Frequency" authored by Doreen Jacob and Dr. Marlin Mickle in the Journal -Otolaryngology-Head and Neck Surgery, 2005)
- VNS Vagus Nerve Stimulation
- AD Alzhiemer's Disease
- refractory epilepsy Conventional medication becomes refractory in certain patients these patients would be most benefited by such treatments.
- VNS Vagus Nerve Stimulation
- AD Alzheimer's disease
- VNS Vagus Nerve Stimulation
- the article, entitled “Cognition-Enhancing Effect of Vagus Nerve Stimulation in Patients with Alzheimer's disease: A Pilot Study” suggests that VNfS Therapy may improve cognition in patients with AD (Sjogren MJ, et. al., J. Clin. Psychiatry, (2002), 63, 972-980.)
- GES Gastric electrical stimulation
- the current device involves use of a pace maker with electrodes going to the stomach.
- Transneuronix pioneered the technique and demonstrated that the technique has affects on obese patients.
- the pacing was described as 24 hours a day, 180-400 ms pulse width, 40-100 Hz; 2 seconds ON, 3 seconds OFF with a burst amplitude of 3-8.5 rnA (Cigaina et.al, Obes Surg. 1999;9:333-334).
- Fig. 1 which consists of a pace maker device that is implanted in the chest and with leads going to the Vagus nerve or to the stomach for gastric electrical stimulation (Lin Z, DigDis ScL, 50, 1328-1334, 2005).
- Implantation of the conventional devices in the pheriphery is costly. As per Fig.l the implantation of the electrode 100 and the implantable pulse generator 120 is sometimes performed on different days. The incisions can be prone to infection in the immediate postoperative period. In some elderly patients with thin skin, the pulse generator 110 or wire can erode through the skin and become exposed to potential contamination. Infection or erosion often results in the need to remove the entire device, as antibiotic treatment alone in this setting rarely will clear the infection adequately. The lead 110 restricts the patient's mobility and may break. Furthermore, the battery 120 must be replaced every three to five years. Additional drawbacks of the pacemaker device include the risk of erosion of the leads or hardware, infection, and magnetic sensitivity.
- this facilitates the remote station being encapsulated within a suitable protective material, such as a resinous plastic. Homopolymers, elastomers and silicon dioxide are also suggested as suitable materials for such purposes. Further, it is suggested that this facilitates miniaturization of the remote station and placing the remote station in functionally desirable locations which need not be readily accessible.
- the remote station for example, could be implanted in a patient.
- an electronic article containing a microchip having at least one antenna structured to communicate with an antenna remotely disposed with respect to the microchip is disclosed in U.S. Patent No. 6,615,074 entitled "Apparatus for Energizing a Remote Station and Related Method". Power enhancement is achieved using a voltage doubler.
- the antenna of the disclosed apparatus is comparable in volume to a Smart Dust device.
- Smart Dust is a combination MEMS/Electronic device on the order of 1 mm x lmm x lmm.
- What is further needed is a device that can be designed as a chip. What is further needed is a device that is made of a chain of chips. What is further needed is a device that is a chip or a chain of chips that can be implanted anywhere in the body. What is also needed is a device that has a power source that does not need to be replaced.
- the device such as the chip, also called BioMed-Chip , for electrical stimulation using RF energy harvesting of the present invention overcomes the disadvantages of the prior art, fulfills the needs in the prior art, and accomplishes its various purposes by providing a stimulation device that harvests radio frequency energy and is implantable in the human body.
- the chip device of the invention may include an electrode on one side that can provide neuro stimulation and a harvesting side on the other.
- the chip device instead of the electrode may have a pouch containing a drug, a protein or a plasmid for localized delivery.
- the chip could have the ability to transmit information to other chips in the body or create an RF field for other chips in the vicinity.
- a chip for stimulation using radio frequency harvesting includes a circuit, the circuit comprising a radio frequency harvesting power circuit and a stimulation circuit, and a plurality of small electrodes coupled to the circuit, the plurality of electrodes provide stimulation to targeted areas of the body.
- the chip devices 230, 300, 420, 530, 610, 900 and 1010 are the same type of radio frequency harvesting chip.
- the chip devices 220, 400, 410 and 620 are harvesting chips that can also generate an RF field. Li the drawings:
- FIG. 1 is a schematic representation of a prior art device for vagus nerve stimulation, 120 is the pacemaker power supply, 110 is the leads, 100 are the electrodes;
- FIG. 2 is a schematic representation of a chip stimulation device using RF energy harvesting in accordance with the invention, 200 is the chip antenna, 210 is the chip microcontroller and 220 is the chip electrode;
- FIG. 3 is a schematic representation of the chip device and its use in the human body using RF energy harvesting in accordance with the invention, 300 is a single harvesting or RF generating chip, 310 is a chain of chips for stimulation, 320 is a ring of chips for stimulation;
- FIG. 4 is a schematic representation of the use of a chain of chip device for gastric electrical stimulation
- 400 is the RF harvesting/generating chip that is located subcutaneously
- 410 is RF harvesting/generating chip stacked in between 400 and the chain of stimulating chips (420), 400 and 410 power 420 in accordance with the invention
- FIG. 5 is a schematic representation of the chip device for localized drug delivery, 500 represents the drug chamber, 510 is the outside of the pouch containing the drug, 520 is the pore through which the drugs are eluted, 530 is the chip device;
- FIG. 6 is a schematic representation of the chip stimulation device for vagus nerve stimulation in accordance with the invention
- 600 is the vagus nerve
- 610 is the ring of chips
- 620 is the RF generating chips as described in Fig 4
- FIG. 7 is a schematic representation of an external programming circuit in accordance with the invention
- FIG. 8 is a schematic representation of an alternative embodiment of the external power circuit non-inductively coupled to the power circuit in accordance with the invention.
- FIG. 9 is an illustration of a band aid layout with a chip electrode that can be used on wounds to provide enhanced healing in accordance with the invention.
- FIG. 10 is an illustration of the use of the chip electrode device (1000) for muscle stimulation using a wrist watch transmitter to power trie chip in accordance with the invention.
- the BioMed-chip consists of a flexible, implantable chip and antennae 200 having a dimension of approxiametly 9 mm 2 and a thickness of between 3 and 4 mm may be formed of a biocompatible material and include circuitry as further described herein. Electrodes 220 may include conventional electrodes or a flat electrode surface.
- the chip has a microcontroller 210.
- the circuitry may be operable to harvest and store RF energy, control the operation of the device and provide stimulation pulses and signals to the targeted areas of the body.
- the chip can be used singly or as a chain or ring of chips.
- BioMed-chips can also generate an RF field to power adjacent chips, or can transmit/ receive data from outside the body or to and from other chips inside the body.
- an RF generation/transmitting circuitry 230 For such chips that can generate an RF field there is an RF generation/transmitting circuitry 230.
- the BioMed-chip will include an antenna for harvesting or transmission, an electrode and a rechargeable storage device, either a thin film battery or capacitor that can be slowly charged over a period of time from the surrounding radio waves present in our environment.
- FIG. 3 A device or "chip” for stimulation using RF energy harvesting of the invention is shown in FIG. 3.
- the flexible, implantable chip 300 can be used as a single chip or as a chain 310 or as a ring 320. Use of a chain of chips inside the body would require stacking of a series of RF generating chips to be placed all the way to under the surface of the skin (subcutaneous).
- 420 is put on the surface of the stomach and used to cause gasric electrical stimulation (GES).
- the electrodes are attached to the surface of the stomach.
- the surgery required for insertion of the chips on the stomach is fairly routine.
- a second (410), third (400) or more RF generating BioMed chips would be put in a stacked fashion upto the surface of the skin (subcutaneous) in order to power the chips on the surface of the stomach.
- the requirement for the RF- field generating chips would vary from patient to patient.
- a pouch 510 on the back of the chip is used to store drug, proteins or plasmids. Stimulation of the pouch chamber 500 results in the release of the drug through the pore 520 or protein to the site at which the chip 530 is placed.
- the chip is implanted to a localized site such as the knee for rheumatoid arthritis where delivery of a drug or therapeutic protein is of value to the specific site. Implantation of the drug chip is done under local anesthesia and is accomplished easily.
- a ring of chips 610 are put on the the vagus nerve as shown in the figure.
- the ring of chips would be clipped on and anchored to the surrounding tissue to prevent migration of the ring.
- the use of one or more RF generating chips 620 more in a stacked fashion to under the skin surface (subcutaneous) is needed to power the ring of chips.
- the procedure is performed under general anesthesia.
- a neurosurgeon implants the ring of chips carefully attaching it to the vagus nerve.
- Implantation of the RF-field generating BioMed chip is then done.
- the number of chips needed would vary from patient to patient. Implantation is usually accomplished within 1 to 2 hours.
- the chips are programmed to stimulate the vagus nerve at regular intervals (e.g., for 30 seconds every 5 minutes) at a frequency determined by the doctor and patient. The physician adjusts the frequency using a computer.
- an example of a device for enhanced wound healing consists of a band aid with a Biomed chip 900 in the center.
- the mild electrical stimulation is delivered through the electrode surface which is in contact with the wound.
- FIGS.10 an example of a chip device for muscle stimulation with a Biomed chip 1010 the powering of the chip is done by an RF transmitter worn on a wrist watch 1000.
- the chip circuitry may include a stimulation circuit as shown in FIG. 2 and a power circuit.
- the chip also has a microcontroller for a chip may manage the internal stimulation circuitry.
- a low frequency receiver may be coupled to the microcontroller and may convert RF communications into programming commands which the microcontroller interprets thus providing for ability to modify the chip functions.
- the microcontroller may be operated with an internal clock frequency of 125 KHz, giving an efficient tradeoff between power conservation and proper functionality. This clock frequency allows pulse durations in increments of 32 micro-seconds. The output pulse duration can be adjusted between —60 and ⁇ 1 80 microseconds.
- the programming input from the low frequency receiver chip 320 may be checked. If a programming signal is present, an input code may be read sequentially and the specified parameter adjusted to a new value, after which the program continues its pulsing routine.
- An external programmer circuit 700 may include a microcontroller 710 including a PIC16LF87, an inductor/capacitor (LC) oscillating circuit 720 (125 KHz), and an intermediate MOSFET driver 730 including a TC4422 as shown in FIG. 7.
- the MOSFET driver 730 may supply enough energy for driving the LC circuit 720.
- a button (not shown) may be pressed, telling the microcontroller 710 to read its inputs and stimulate the MOSFET driver 730 to oscillate the LC circuit 720 according to a communication protocol.
- Input voltages may be controlled by simple switches. Four switches may dictate the value to be sent, while five switches may dictate which parameter is to be changed.
- a Phidget RFID antenna 740 designed for 125 KHz maybe attached to the high voltage side of a capacitor 750 of the LC circuit 720 for sending the programming signal.
- the circuit 700 may be powered via a 12- Volt wall supply. The 12 V drives the MOSFET driver 730 and is regulated to 5 V for the switches and microcontroller 710.
- An external powering circuit 800 may in one embodiment described above provide for near field harvesting and includes inductive coupling between coils 835 and 840.
- the power circuit 865 for powering the stimulation circuit maybe non-inductively coupled to an external source of RF energy 880.
- the power circuit 865 may be disposed in a wrist band worn by the patient, in a room transmitter or in a transmitter disposed in a building occupied by the patient.
- the power circuit 865 may harvest ambient RF energy such as energy transmitted in space by using an inherently tuned antenna as described in U.S. Patent No. 6,856,291, the description of which is incorporated by reference in its entirety herein.
- a rechargeable battery or other storage device may be employed to store harvested energy. "Non-inductive" as described herein being directed RF.
Landscapes
- Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Electrotherapy Devices (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61975704P | 2004-10-18 | 2004-10-18 | |
US60/619,757 | 2004-10-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006045054A2 true WO2006045054A2 (fr) | 2006-04-27 |
WO2006045054A3 WO2006045054A3 (fr) | 2007-02-22 |
Family
ID=36203713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/037928 WO2006045054A2 (fr) | 2004-10-18 | 2005-10-18 | Dispositif de stimulation du corps neuromusculaire, peripherique et stimulation(s) electrique(s) dans la suberification d'une blessure par recuperation d'energie radioelectrique |
Country Status (2)
Country | Link |
---|---|
US (1) | US20060161216A1 (fr) |
WO (1) | WO2006045054A2 (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8914114B2 (en) | 2000-05-23 | 2014-12-16 | The Feinstein Institute For Medical Research | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
JP2007530586A (ja) | 2004-03-25 | 2007-11-01 | ザ ファインスタイン インスティテュート フォー メディカル リサーチ | 神経性止血法 |
US10912712B2 (en) | 2004-03-25 | 2021-02-09 | The Feinstein Institutes For Medical Research | Treatment of bleeding by non-invasive stimulation |
US11207518B2 (en) | 2004-12-27 | 2021-12-28 | The Feinstein Institutes For Medical Research | Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway |
EP1833559B1 (fr) | 2004-12-27 | 2010-11-24 | The Feinstein Institute for Medical Research | Traitement de troubles inflammatoires par la stimulation electrique du nerf vague |
EP1903000B1 (fr) * | 2006-09-25 | 2019-09-18 | Sorin CRM SAS | Composant biocompatible implantable incorporant un élément actif intégré tel qu'un capteur de mesure d'un paramètre physiologique, microsystème électromécanique ou circuit électronique |
US20080154331A1 (en) * | 2006-12-21 | 2008-06-26 | Varghese John | Device for multicentric brain modulation, repair and interface |
US8391970B2 (en) | 2007-08-27 | 2013-03-05 | The Feinstein Institute For Medical Research | Devices and methods for inhibiting granulocyte activation by neural stimulation |
US9662490B2 (en) | 2008-03-31 | 2017-05-30 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug |
WO2009146030A1 (fr) | 2008-03-31 | 2009-12-03 | The Feinstein Institute For Medical Research | Méthodes et systèmes de réduction d’une inflammation par neuromodulation de l’activité des lymphocytes t |
US8412338B2 (en) | 2008-11-18 | 2013-04-02 | Setpoint Medical Corporation | Devices and methods for optimizing electrode placement for anti-inflamatory stimulation |
US9211410B2 (en) | 2009-05-01 | 2015-12-15 | Setpoint Medical Corporation | Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
US8996116B2 (en) | 2009-10-30 | 2015-03-31 | Setpoint Medical Corporation | Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction |
US8788034B2 (en) | 2011-05-09 | 2014-07-22 | Setpoint Medical Corporation | Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
WO2010144578A2 (fr) | 2009-06-09 | 2010-12-16 | Setpoint Medical Corporation | Manchon pour nerf muni d'une poche pour stimulateur sans fil |
WO2014169145A1 (fr) | 2013-04-10 | 2014-10-16 | Setpoint Medical Corporation | Stimulation de nerf vague en boucle fermée |
US20110115605A1 (en) * | 2009-11-17 | 2011-05-19 | Strattec Security Corporation | Energy harvesting system |
US9833621B2 (en) | 2011-09-23 | 2017-12-05 | Setpoint Medical Corporation | Modulation of sirtuins by vagus nerve stimulation |
EP2515996B1 (fr) | 2009-12-23 | 2019-09-18 | Setpoint Medical Corporation | Dispositifs de stimulation neurale et systèmes pour le traitement d'une inflammation chronique |
EP4424360A2 (fr) | 2011-01-28 | 2024-09-04 | Curonix LLC | Système de stimulateur neuronal |
US12115374B2 (en) * | 2011-01-28 | 2024-10-15 | Curonix Llc | Microwave field stimulator |
US9220897B2 (en) | 2011-04-04 | 2015-12-29 | Micron Devices Llc | Implantable lead |
WO2012138782A1 (fr) | 2011-04-04 | 2012-10-11 | Stimwave Technologies Incorporated | Conducteur implantable |
JP2014524279A (ja) | 2011-07-29 | 2014-09-22 | スティムウェイブ テクノロジーズ インコーポレイテッド | 神経刺激器のための電力又は極性選択の遠隔制御 |
WO2013025632A1 (fr) * | 2011-08-12 | 2013-02-21 | Stimwave Technologies Incorporated | Stimulateur de champs hyperfréquences |
TR201802844T4 (tr) | 2011-09-15 | 2018-03-21 | Andresen Chad | İmplant için röle modülü. |
US9572983B2 (en) | 2012-03-26 | 2017-02-21 | Setpoint Medical Corporation | Devices and methods for modulation of bone erosion |
US9254393B2 (en) | 2012-12-26 | 2016-02-09 | Micron Devices Llc | Wearable antenna assembly |
WO2015042558A1 (fr) * | 2013-09-23 | 2015-03-26 | Board Of Regents, The University Of Texas System | Dispositifs de stimulation tissulaire sans fil |
CN110665114B (zh) | 2014-05-12 | 2022-12-06 | 斯蒂维科技公司 | 具有小尺寸发射天线的远程rf功率系统 |
US11311725B2 (en) | 2014-10-24 | 2022-04-26 | Setpoint Medical Corporation | Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation |
WO2016126807A1 (fr) | 2015-02-03 | 2016-08-11 | Setpoint Medical Corporation | Appareil et procédé de rappel, d'incitation ou d'alerte d'un patient ayant un stimulateur implanté |
US10596367B2 (en) | 2016-01-13 | 2020-03-24 | Setpoint Medical Corporation | Systems and methods for establishing a nerve block |
US11471681B2 (en) | 2016-01-20 | 2022-10-18 | Setpoint Medical Corporation | Batteryless implantable microstimulators |
WO2017127756A1 (fr) | 2016-01-20 | 2017-07-27 | Setpoint Medical Corporation | Commande de stimulation vagale |
US10314501B2 (en) | 2016-01-20 | 2019-06-11 | Setpoint Medical Corporation | Implantable microstimulators and inductive charging systems |
US10583304B2 (en) | 2016-01-25 | 2020-03-10 | Setpoint Medical Corporation | Implantable neurostimulator having power control and thermal regulation and methods of use |
WO2019036470A1 (fr) | 2017-08-14 | 2019-02-21 | Setpoint Medical Corporation | Test de dépistage pour stimulation du nerf vague |
US11260229B2 (en) | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
CA3178409A1 (fr) | 2020-05-21 | 2021-11-25 | Stavros ZANOS | Systemes et methodes de stimulation du nerf vague |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5314458A (en) * | 1990-06-01 | 1994-05-24 | University Of Michigan | Single channel microstimulator |
US6141588A (en) * | 1998-07-24 | 2000-10-31 | Intermedics Inc. | Cardiac simulation system having multiple stimulators for anti-arrhythmia therapy |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5383915A (en) * | 1991-04-10 | 1995-01-24 | Angeion Corporation | Wireless programmer/repeater system for an implanted medical device |
DE4329898A1 (de) * | 1993-09-04 | 1995-04-06 | Marcus Dr Besson | Kabelloses medizinisches Diagnose- und Überwachungsgerät |
AU1057697A (en) * | 1995-11-24 | 1997-06-11 | Advanced Bionics Corporation | System and method for conditioning pelvic musculature using an implanted microstimulator |
US6463328B1 (en) * | 1996-02-02 | 2002-10-08 | Michael Sasha John | Adaptive brain stimulation method and system |
EP0892654B1 (fr) * | 1996-04-04 | 2003-06-11 | Medtronic, Inc. | Dispositif pour stimulation et enregistrement pour tissus vivants |
FR2796562B1 (fr) * | 1996-04-04 | 2005-06-24 | Medtronic Inc | Techniques de stimulation d'un tissu vivant et d'enregistrement avec commande locale de sites actifs |
US5713922A (en) * | 1996-04-25 | 1998-02-03 | Medtronic, Inc. | Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain |
US5716377A (en) * | 1996-04-25 | 1998-02-10 | Medtronic, Inc. | Method of treating movement disorders by brain stimulation |
US5843148A (en) * | 1996-09-27 | 1998-12-01 | Medtronic, Inc. | High resolution brain stimulation lead and method of use |
WO1999006108A1 (fr) * | 1997-08-01 | 1999-02-11 | Alfred E. Mann Foundation For Scientific Research | Dispositif implantable a configuration amelioree d'alimentation et de recharge de batterie |
US6066165A (en) * | 1998-04-30 | 2000-05-23 | Racz; Gabor B | Medical lead with sigma feature |
US6319241B1 (en) * | 1998-04-30 | 2001-11-20 | Medtronic, Inc. | Techniques for positioning therapy delivery elements within a spinal cord or a brain |
US6253109B1 (en) * | 1998-11-05 | 2001-06-26 | Medtronic Inc. | System for optimized brain stimulation |
US6615074B2 (en) * | 1998-12-22 | 2003-09-02 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Apparatus for energizing a remote station and related method |
US6289237B1 (en) * | 1998-12-22 | 2001-09-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Apparatus for energizing a remote station and related method |
US20050055064A1 (en) * | 2000-02-15 | 2005-03-10 | Meadows Paul M. | Open loop deep brain stimulation system for the treatment of Parkinson's Disease or other disorders |
US7756584B2 (en) * | 2000-07-13 | 2010-07-13 | Advanced Neuromodulation Systems, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US7010351B2 (en) * | 2000-07-13 | 2006-03-07 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US7146217B2 (en) * | 2000-07-13 | 2006-12-05 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a change in a neural-function of a patient |
US7024247B2 (en) * | 2001-10-15 | 2006-04-04 | Northstar Neuroscience, Inc. | Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures |
US6901292B2 (en) * | 2001-03-19 | 2005-05-31 | Medtronic, Inc. | Control of externally induced current in an implantable pulse generator |
US6671555B2 (en) * | 2001-04-27 | 2003-12-30 | Medtronic, Inc. | Closed loop neuromodulation for suppression of epileptic activity |
US7024249B2 (en) * | 2002-02-21 | 2006-04-04 | Alfred E. Mann Foundation For Scientific Research | Pulsed magnetic control system for interlocking functions of battery powered living tissue stimulators |
US6856291B2 (en) * | 2002-08-15 | 2005-02-15 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Energy harvesting circuits and associated methods |
US7373133B2 (en) * | 2002-09-18 | 2008-05-13 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Recharging method and apparatus |
US7440780B2 (en) * | 2002-09-18 | 2008-10-21 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Recharging method and apparatus |
US20050075679A1 (en) * | 2002-09-30 | 2005-04-07 | Gliner Bradford E. | Methods and apparatuses for treating neurological disorders by electrically stimulating cells implanted in the nervous system |
US7047084B2 (en) * | 2002-11-20 | 2006-05-16 | Advanced Neuromodulation Systems, Inc. | Apparatus for directionally stimulating nerve tissue |
US7565199B2 (en) * | 2002-12-09 | 2009-07-21 | Advanced Neuromodulation Systems, Inc. | Methods for treating and/or collecting information regarding neurological disorders, including language disorders |
JP2006526979A (ja) * | 2003-06-02 | 2006-11-24 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 空間からエネルギーを得るための、チップ又はプリント回路基板のようなワイヤレスアンテザードデバイス上のアンテナ |
KR100947180B1 (ko) * | 2003-06-03 | 2010-03-15 | 엘지디스플레이 주식회사 | 폴리실리콘 박막트랜지스터의 제조방법 |
US7084605B2 (en) * | 2003-10-29 | 2006-08-01 | University Of Pittsburgh | Energy harvesting circuit |
US7107097B2 (en) * | 2004-01-14 | 2006-09-12 | Northstar Neuroscience, Inc. | Articulated neural electrode assembly |
US7471986B2 (en) * | 2004-02-20 | 2008-12-30 | Cardiac Pacemakers, Inc. | System and method for transmitting energy to and establishing a communications network with one or more implanted devices |
CA2573763A1 (fr) * | 2004-07-15 | 2006-02-23 | Northstar Neuroscience, Inc. | Systemes et methodes pour augmenter ou influer sur l'efficience et/ou l'efficacite d'une stimulation neurale |
US20060184209A1 (en) * | 2004-09-02 | 2006-08-17 | John Constance M | Device for brain stimulation using RF energy harvesting |
US20060173509A1 (en) * | 2004-10-05 | 2006-08-03 | Dartmouth College | Deep brain stimulator |
EP1804912A2 (fr) * | 2004-10-05 | 2007-07-11 | Dartmouth College | Appareil et procede de modulation de niveaux d'agents neurochimiques dans le cerveau |
US7565200B2 (en) * | 2004-11-12 | 2009-07-21 | Advanced Neuromodulation Systems, Inc. | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects |
WO2006069144A2 (fr) * | 2004-12-21 | 2006-06-29 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Appareil de stimulation cerebrale profonde, et procedes associes |
EP1723983B1 (fr) * | 2005-05-20 | 2013-07-10 | Imec | Sonde permettant la stimulation électrique de cellules excitables et l'enregistrement de leur activité |
-
2005
- 2005-10-18 WO PCT/US2005/037928 patent/WO2006045054A2/fr active Application Filing
- 2005-10-18 US US11/253,905 patent/US20060161216A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5314458A (en) * | 1990-06-01 | 1994-05-24 | University Of Michigan | Single channel microstimulator |
US6141588A (en) * | 1998-07-24 | 2000-10-31 | Intermedics Inc. | Cardiac simulation system having multiple stimulators for anti-arrhythmia therapy |
Also Published As
Publication number | Publication date |
---|---|
WO2006045054A3 (fr) | 2007-02-22 |
US20060161216A1 (en) | 2006-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060161216A1 (en) | Device for neuromuscular peripheral body stimulation and electrical stimulation (ES) for wound healing using RF energy harvesting | |
US11351364B2 (en) | Apparatus, system, and method for selective stimulation | |
CA2618171C (fr) | Generateur d'impulsions implantable alimente par un ultracondensateur a alimentation specifique | |
US10143850B2 (en) | Systems and methods for implantable leadless tissue stimulation | |
EP1984066B1 (fr) | Système rfid de traitement thérapeutique d'un patient | |
EP1648559B1 (fr) | Dispositif de stimulation implantable a alimentation acoustique | |
WO2011072183A2 (fr) | Système de neurostimulation implantable | |
US20240307692A1 (en) | Implantable medical device control system and control method therefor | |
US20060136007A1 (en) | Deep brain stimulation apparatus, and associated methods | |
KR102162058B1 (ko) | 체내 이식형 의료기기 제어시스템 및 그의 제어방법 | |
KR102162060B1 (ko) | 체내 이식형 의료기기 제어시스템 및 그의 제어방법 | |
KR102162063B1 (ko) | 체내 이식형 의료기기 제어시스템 및 그의 제어방법 | |
AU2012201366B2 (en) | An RFID based apparatus, system, and method for therapeutic treatment of a patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC AS PER OUR LETTER OF 04.07.2007 (EPO FORM 1205A) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05816580 Country of ref document: EP Kind code of ref document: A2 |